Research news

Date
Summary

New international research suggests that too much calcium inside brain cells may trigger a chain reaction that leads to Parkinson's.

Date
Summary

We're partnering with US company Neurolixis to accelerate the development of a drug that could prevent dyskinesia, a debilitating side effect of Parkinson's medication.

Date
Summary

International pharmaceutical company, Pfizer, has announced a move to end all early-stage projects in neuroscience.

Date
Summary

Research supported by Parkinson's UK has identified a medicine used to treat tapeworm infections which could lead to new treatments for people with Parkinson's.